Tenofovir CAS:147127-20-6
Catalog Number | XD95604 |
Product Name | Tenofovir |
CAS | 147127-20-6 |
Molecular Formula | C9H14N5O4P |
Molecular Weight | 287.21 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Tenofovir is an antiviral medication that belongs to the class of drugs known as nucleoside reverse transcriptase inhibitors. It is primarily used in the treatment of human immunodeficiency virus (HIV) infection and chronic hepatitis B infection. Tenofovir works by blocking the activity of reverse transcriptase, an enzyme that is essential for the replication of the virus.One of the most significant effects of tenofovir is its ability to suppress viral replication. By inhibiting reverse transcriptase, the drug prevents the conversion of the viral RNA into DNA, which is necessary for the virus to reproduce. This helps to reduce the viral load in the body, slow down the progression of the infection, and improve the immune system's ability to fight the virus.Tenofovir has also been shown to have a high barrier to resistance. This means that the virus is less likely to develop resistance to the medication compared to other antiretroviral drugs. This is an important characteristic in the treatment of HIV, as drug resistance can limit the effectiveness of treatment options.Furthermore, tenofovir has shown efficacy in the prevention of HIV infection when used as pre-exposure prophylaxis (PrEP). Studies have demonstrated that daily use of tenofovir, in combination with another antiretroviral drug called emtricitabine, can significantly reduce the risk of HIV transmission in high-risk individuals, such as those in serodiscordant relationships or engaging in unprotected sexual activity.In addition to its antiviral effects, tenofovir has been found to have a favorable safety profile. However, like any medication, it can have side effects, including gastrointestinal disturbances, renal toxicity, and decreased bone density, particularly with long-term use. Close monitoring of renal function and bone health is therefore essential in individuals receiving tenofovir therapy.In conclusion, tenofovir is a potent antiviral medication used in the treatment of HIV infection and chronic hepatitis B. Its ability to suppress viral replication, high barrier to resistance, and effectiveness as PrEP make it a valuable tool in the management and prevention of these infections. However, it is crucial to be aware of potential side effects and monitor patients closely to ensure safety and optimize treatment outcomes.